miRNA-767 and its binding site polymorphism in the mTOR gene act as potential biomarkers for female reproductive cancers
Future Oncology · 2023
DOI: 10.2217/fon-2022-1055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Oncology, 2023. Verfasst von Rabia Shafique und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Genetics & Epigenetics Research Group, Department of Biosciences, COMSATS University, Park Road Islamabad, Pakistan. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Aims
The present study aimed to understand the relationship between the mTOR gene SNP (rs2536) and reproductive cancer risk. The expression level of miRNA-767 was also assessed.
Methods
700 tumor samples (300 breast, 200 ovarian and 200 cervical cancers), along with adjacent uninvolved control tissue, were used. rs2536 was screened using Tetra-ARMS PCR and expression level of miRNA-767 was assessed using quantitative PCR.
Results
The frequency of the homozygous mutant genotype of rs2536 was observed significantly higher in breast (p < 0.04), ovarian (p < 0.005) and cervical (p < 0.003) cancers. Significant downregulation of miRNA-767 was observed in tumors compared with controls.
Conclusion
The present study demonstrates that increased mutant frequency of rs2536 and deregulation of miRNA-767 are associated with increased reproductive cancer risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Genetics & Epigenetics Research Group, Department of Biosciences, COMSATS University, Park Road Islamabad, Pakistan.
- Department of Pathology, Sir Ganga Ram Hospital, Lahore, Pakistan.
ORCID-Profile: Ishrat Mahjabeen, Muhammad Rizwan, Nida Sarosh Ashraf, Mahmood Akhtar Kayani
Zitieren
APA
Shafique, R., Mahjabeen, I., Bibi, K., Kalsoom, F., Rizwan, M., Ashraf, N. S., Mehmood, A., Ul Haq, M. F., Abbasi, S. F., Saeed, N., & Kayani, M. A. (2023). miRNA-767 and its binding site polymorphism in the mTOR gene act as potential biomarkers for female reproductive cancers. Future Oncology. https://doi.org/10.2217/fon-2022-1055
Vancouver
Shafique R, Mahjabeen I, Bibi K, Kalsoom F, Rizwan M, Ashraf NS, et al. miRNA-767 and its binding site polymorphism in the mTOR gene act as potential biomarkers for female reproductive cancers. Future Oncology. 2023. doi:10.2217/fon-2022-1055
BibTeX
@article{Shafique2023,
author = {Shafique, Rabia and Mahjabeen, Ishrat and Bibi, Kashaf and Kalsoom, Farah and Rizwan, Muhammad and Ashraf, Nida Sarosh and Mehmood, Azhar and Ul Haq, Maria Fazal and Abbasi, Sumaira Fida and Saeed, Nadia and Kayani, Mahmood Akhtar},
title = {miRNA-767 and its binding site polymorphism in the mTOR gene act as potential biomarkers for female reproductive cancers},
journal = {Future Oncology},
year = {2023},
doi = {10.2217/fon-2022-1055}
}
EUVIMED